STUDIES ON THE DRUG-INTERACTION OF DILTIAZEM .2. EFFECT OF COADMINISTERED DILTIAZEM ON THE BIOAVAILABILITY OF PROPRANOLOL

被引：6

作者：

ETOH, A ^{[1
]}

KOHNO, K ^{[1
]}

SHIMIZU, T ^{[1
]}

机构：

[1] CHUKYO HOSP, MINAMI KU, NAGOYA, JAPAN

来源：

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 1983年 / 103卷 / 04期

关键词：

D O I：

10.1248/yakushi1947.103.4_434

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：434 / 441

页数：8

共 14 条

[1]

DONOVAN MA, 1981, LANCET, V1, P164

[2]

GIBALDI M, 1972, J PHARM SCI, V61, P70

[3]

GRABOWSKI BS, 1980, INT J CLIN PHARM TH, V18, P317

[4]

HEARGERTY AM, 1981, BRIT MED J, V282, P1917

[5] THE INFLUENCE OF VERAPAMIL ON SERUM DIGOXIN CONCENTRATION [J].

KLEIN, HO ;

LANG, R ;

WEISS, E ;

DISEGNI, E ;

LIBHABER, C ;

GUERRERO, J ;

KAPLINSKY, E .

CIRCULATION, 1982, 65 (05) :998-1003

[6]

KORNHAUSER DM, 1978, CLIN PHARMACOL THER, V23, P165

[7] INTERACTION BETWEEN ORAL PROPRANOLOL AND HYDRALAZINE [J].

MCLEAN, AJ ;

SKEWS, H ;

BOBIK, A ;

DUDLEY, FJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (06) :726-732

[8]

MELANDER A, 1977, CLIN PHARMACOL THER, V22, P108

[9]

NIES A S, 1976, Clinical Pharmacokinetics, V1, P135, DOI 10.2165/00003088-197601020-00005

[10]

PEDERSEN KE, 1981, CLIN PHARMACOL THER, V30, P311

← 1 2 →